Pyxis Oncology Stock Volatility
| PYXS Stock | USD 1.83 0.07 3.98% |
Sharpe Ratio = 0.0795
| Leading Returns | Top Quartile | |||
| Strong | ||||
| Moderate | ||||
| Modest | PYXS | |||
| Cash | Low | Moderate | Elevated | High |
| Below Benchmark |
Pyxis Oncology reported a Market Risk Adjusted Performance of 0.3%, a Risk of 5.06, and a Risk Adjusted Performance of 0.1%. Based on monthly moving averages, the stock is operating near 6% of its historical performance range.
Key indicators related to Pyxis Oncology's volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Key risk metrics for Pyxis Oncology (3 Months):
Beta 1.62 | Alpha 0.44 | Risk 5.06 | Sharpe Ratio 0.08 | Expected Return 0.4 |
Moving together with Pyxis Oncology Stock
| 0.61 | CSCO | Cisco Systems Earnings Call This Week | PairCorr |
Moving Against Pyxis Oncology Stock
| 0.62 | VZ | Verizon Communications | PairCorr |
| 0.54 | MCD | McDonalds Earnings Call Tomorrow | PairCorr |
| 0.45 | PFE | Pfizer Inc | PairCorr |
| 0.44 | XOM | Exxon Mobil Corp | PairCorr |
| 0.4 | MMM | 3M Company | PairCorr |
Sensitivity To Market
Pyxis Oncology beta coefficient measures the volatility of Pyxis Oncology stock relative to the systematic risk of the broad market benchmark. A beta of 1.62 indicates the degree of sensitivity to market-wide movements. Current total volatility is approximately 5.06%. Pyxis Oncology has shown noticeable price swings over the selected period. Downside deviation is about 4.9% and standard deviation is about 5.02%, which summarize how widely returns have moved. For individual stocks, volatility often rises around earnings, guidance updates, and major company news.
3 Months Beta |Pyxis Oncology Demand TrendCurrent 90-day Pyxis Oncology correlation with market (Dow Jones Industrial)Downside Risk
Standard deviation measures how far Pyxis Oncology returns deviate from the historical mean and remains a primary indicator of total price volatility. A large standard deviation signals wide price swings; a small one signals relative stability.
Standard Deviation | 5.06 |
It is essential to understand the difference between upside risk and downside risk for Pyxis Oncology. Total volatility includes favorable moves, while downside deviation isolates the loss risk in Pyxis Oncology's daily returns. Pyxis Oncology reported a Downside Deviation of 4.90, a Downside Variance of 24.06, and a Maximum Drawdown of 24.00.
Stock Volatility Analysis
Volatility refers to the frequency at which Pyxis Oncology stock price increases or decreases within a specified period. It is generally measured from either the standard deviation or variance between returns from that same stock.
Transformation |
This analysis covers sixty-one data points across the selected time horizon. The Average Price transformation calculates the mean of Pyxis Oncology's open, high, low, and close for each trading period. By incorporating all four price components equally, it provides a balanced representation of each period's trading activity. Compared to using the closing price alone, the average price reduces the influence of end-of-day positioning and can serve as a smoother input for other technical indicators.
Projected Return Density Against Market
Given a 90-day horizon, Pyxis Oncology has a beta of 1.62 indicating when the benchmark rises, PYXS tends to outperform it on average. However, when benchmark returns turn negative, Pyxis Oncology tends to underperform.Pyxis Oncology is exposed to both systematic and unsystematic risk. Systematic risk reflects broader stock market movements, while company or sector-specific developments represent nonmarket drivers. Diversification may reduce specific risk, but market exposure remains. Beta and standard deviation help quantify volatility. Pyxis Oncology reported a Downside Deviation of 4.90, a Mean Deviation of 3.64, and a Semi Deviation of 4.49.
Predicted Return Distribution |
| Density |
What Drives Pyxis Oncology's Price Volatility?
Industry Dynamics
Regulatory updates, demand shifts, and competitive changes in the Biotechnology sector can move Pyxis Oncology's volatility even when broad indices are stable.Political and Economic Environment
Rates, inflation expectations, and policy headlines can shift discount rates and risk appetite for Pyxis Oncology.Pyxis Oncology's Company-Specific Factors
Earnings surprises, guidance changes, management decisions, and litigation risk are common catalysts for sharp re-pricing in Pyxis Oncology's shares.Stock Risk Measures
Given a 90-day horizon, the coefficient of variation of Pyxis Oncology is 1257.83. The daily returns are distributed with a variance of 25.6 and standard deviation of 5.06. The mean deviation of Pyxis Oncology is currently at 3.68. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.97
α | Alpha over Dow Jones | 0.44 | |
β | Beta against Dow Jones | 1.62 | |
σ | Overall volatility | 5.06 | |
Ir | Information ratio | 0.09 |
Stock Return Volatility
Pyxis Oncology historical daily return volatility represents how much of Pyxis Oncology stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm reported 5.0594% volatility on return distribution over a 90-day investment horizon. By contrast, Dow Jones Industrial reported 0.9671% volatility on return distribution over a 90-day investment horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
Strong recent returns in Pyxis Oncology Stock do not always mean Pyxis Oncology Company is outperforming peers on business quality. Risk-adjusted metrics help compare Pyxis Oncology's efficiency and downside exposure against peers on a like-for-like basis. These indicators are quantitative in nature and measure volatility and risk-adjusted expected returns across different positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ENTA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| IMRX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| FHTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CRBU | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| VYGR | 2.90 | 0.16 | 0.04 | 0.12 | 3.81 | 5.38 | 30.91 | |||
| TNYA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| AVIR | 2.33 | 0.54 | 0.22 | 0.84 | 2.06 | 6.43 | 16.80 | |||
| ZURA | 3.03 | -0.15 | 0.00 | -0.12 | 0.00 | 6.00 | 17.83 | |||
| HUMA | 5.94 | 0.22 | 0.03 | 0.07 | 7.29 | 8.97 | 49.60 |
Risk Metrics, Assumptions & Methodology
Drawdown depth for Pyxis Oncology defines the worst peak-to-trough loss observed, framing downside volatility in practical terms. Historical performance suggests relatively contained downside variability. Pyxis Oncology has a market cap of 110.63 million, ROE of -91.44%.
Pyxis Oncology values are built from periodic company reporting and market reference feeds, with reporting definitions aligned before display. Volatility and downside metrics are estimated from historical return dispersion.
Editorial review and methodology oversight provided by: Ellen Johnson, Member of Macroaxis Editorial Board
Volatility Profile Summary
Recent data suggests that Pyxis Oncology is more volatile than Dow Jones Industrial by approximately 5.22x over the selected horizon. This differential reflects the relative dispersion of returns and frames how the asset responds to broader market conditions. Observed price behavior indicates modest directional movement within the current volatility regime. Across the current 90-day horizon, that places the security below 45% of the broader equity and portfolio universe on a pure volatility basis. This positioning reflects relative dispersion compared to peers rather than extreme instability.Pyxis Oncology with characteristics aligned to broad market upside participation. This directional read frames the latest price swing through a simple momentum and follow-through lens. It works best as a directional cue rather than as a standalone forecast. an unexpected upward trend with elevated sensitivity to market signals. Return distributions derived from historical modeling outline a range of potential outcomes over the selected 90-day horizon. View Pyxis Oncology probability analysis.
Moderate diversification
For the present investment horizon, the measured correlation between Pyxis Oncology and Dow Jones stands at 0.28, or Moderate diversification. In portfolio terms, the overlap shows how much shared movement remains after combining both positions.
Additional Risk Indicators
A broader risk-indicator set for Pyxis Oncology extends the analysis beyond standard volatility and risk measures. Cross-security comparison within similar growth and valuation profiles provides additional context for interpreting relative risk positioning.
| Risk Adjusted Performance | 0.0907 | |||
| Market Risk Adjusted Performance | 0.2676 | |||
| Mean Deviation | 3.64 | |||
| Semi Deviation | 4.49 | |||
| Downside Deviation | 4.9 | |||
| Coefficient Of Variation | 1175.15 | |||
| Standard Deviation | 5.02 |
Pyxis Oncology Suggested Diversification Pairs
A paired position built around Pyxis Oncology reduces directional market exposure while expressing a relative-value view. Pair trading is less about prediction in isolation and more about identifying relative mispricing between related positions.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Pyxis Oncology as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Pyxis Oncology's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Pyxis Oncology's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Pyxis Oncology.
Additional Tools for Pyxis Oncology Stock Analysis
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modulesIdea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideasPortfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targetsPortfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market riskInsider ScreenerFind insiders across different sectors to evaluate their impact on performancePrice Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instrumentsSync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.Latest PortfoliosQuick portfolio dashboard that showcases your latest portfoliosMoney Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators